Metraipolis › archive › dc_896ebaf07174
Real-world safety profile of givinostat: an early post-marketing pharmacovigilance study based on the FAERS database — Europe PMC PMID:42494524
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42494524
- DOI
- 10.3389/fphar.2026.1861893
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T16:10:04.048Z
- SHA-256 of the archived text
54129750ed871ae4a861a45573c1bc216acd4c966b1664e3b79239c067366aab- Stable URL of this page
https://metraipolis.com/documento/dc_896ebaf07174
How to cite
Real-world safety profile of givinostat: an early post-marketing pharmacovigilance study based on the FAERS database — Europe PMC PMID:42494524 — Europe PMC (en), https://europepmc.org/article/MED/42494524 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_896ebaf07174 (Metraipolis archive dc_896ebaf07174, sha256 54129750ed871ae4a861a45573c1bc216acd4c966b1664e3b79239c067366aab)
BibTeX
@misc{dc896ebaf07174,
title = {Real-world safety profile of givinostat: an early post-marketing pharmacovigilance study based on the FAERS database — Europe PMC PMID:42494524},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42494524},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_896ebaf07174; sha256 54129750ed871ae4a861a45573c1bc216acd4c966b1664e3b79239c067366aab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42494524. Agents can read the archived copy with the MCP tool read_document.